Systematic Review / Meta-Analysis / Ongoing research
Integrating Alternative Splicing And Genetic Variation To Predict Therapy Resistance In Advanced Prostate Cancer: A Systematic Review And Meta-Analysis
01 / OVERVIEW
Overview
A systematic review and meta-analysis of 19,304 patients examining alternative splicing alterations and therapy resistance in metastatic castration-resistant prostate cancer (mCRPC).
This review and meta-analysis examines the impact of alternative splicing alterations on therapeutic resistance in metastatic castration-resistant prostate cancer. The CV reports a combined patient count of 19,304.
02 / CONTEXT
Research context
Therapy resistance in advanced prostate cancer motivates investigation of RNA regulation and genetic variation.
03 / METHOD
Methodological approach
Systematic review and meta-analysis of 19,304 patients, as reported in the CV.
STATUS
Publication status
Under Review. Journal, DOI, and publication details will be listed once confirmed.
PRESENTED AT
Related conference
Asian Scholar International Conference 2026